Trump Names Tomas Philipson as Second Member of Council of Economic Advisers
Prof. Tomas Philipson appointed to Council of Economic Advisers
Does Disneyland Provide a Guide to the Future of Personalized Medicine?
Prof. Tomas Philipson explains framework for pricing personalized medicine
Economic Nonsense From the U.N. on Drugs
In op-ed, Prof. Tomas Philipson critiques UN proposals on pharmaceutical patent laws
Why Democrats And Republicans Are Both Wrong In The Obamacare Repeal Debate
In op-ed, Prof. Tomas Philipson talks about fiscal impacts of Obamacare
Should Investors Pay Attention To The Alleged Productivity Crises In Pharma?
In op-ed, Prof. Tomas Philipson, student Kristopher Hult argue pharmaceutical R&D contributes more to patient improvement than new drugs
Medical Breakthroughs And Credit Markets
In op-ed, Prof. Tomas J. Philipson discusses better credit mechanisms to manage health care technology’s steep upfront costs but long-term benefits
Faculty receive endowed chairs; first Neubauer fellows join the faculty
University of Chicago Chronicle